Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neovascularization, Pathologic | 38 | 2021 | 2627 | 3.170 |
Why?
|
Neovascularization, Physiologic | 17 | 2021 | 1368 | 2.730 |
Why?
|
Corneal Neovascularization | 12 | 2021 | 184 | 2.610 |
Why?
|
Angiogenesis Inhibitors | 21 | 2013 | 2055 | 1.830 |
Why?
|
Vascular Endothelial Growth Factor A | 28 | 2021 | 3511 | 1.790 |
Why?
|
Sesquiterpenes | 11 | 2013 | 175 | 1.270 |
Why?
|
Fibroblast Growth Factor 2 | 16 | 2017 | 590 | 1.110 |
Why?
|
Endometriosis | 10 | 2013 | 873 | 0.980 |
Why?
|
Cornea | 15 | 2014 | 1316 | 0.940 |
Why?
|
Peptide Fragments | 6 | 2021 | 5141 | 0.930 |
Why?
|
Angiogenesis Inducing Agents | 5 | 2017 | 254 | 0.890 |
Why?
|
Endothelial Cells | 13 | 2020 | 3582 | 0.870 |
Why?
|
Thalidomide | 6 | 2013 | 886 | 0.850 |
Why?
|
Choroidal Neovascularization | 4 | 2022 | 364 | 0.840 |
Why?
|
Trabecular Meshwork | 1 | 2022 | 101 | 0.800 |
Why?
|
Cadmium | 1 | 2023 | 218 | 0.780 |
Why?
|
Metals, Heavy | 1 | 2023 | 149 | 0.770 |
Why?
|
Melanocytes | 2 | 2014 | 509 | 0.710 |
Why?
|
Proteoglycans | 3 | 2014 | 807 | 0.700 |
Why?
|
Mice, Inbred C57BL | 41 | 2021 | 22361 | 0.690 |
Why?
|
Cyclohexanes | 10 | 2011 | 151 | 0.680 |
Why?
|
Estradiol | 7 | 2008 | 1951 | 0.660 |
Why?
|
Mice | 66 | 2022 | 81912 | 0.600 |
Why?
|
Pericytes | 1 | 2020 | 298 | 0.580 |
Why?
|
Extracellular Matrix Proteins | 3 | 2022 | 832 | 0.570 |
Why?
|
Teratogens | 2 | 2013 | 119 | 0.560 |
Why?
|
Mice, Inbred Strains | 7 | 2017 | 1765 | 0.550 |
Why?
|
Hydrolases | 1 | 2017 | 146 | 0.540 |
Why?
|
Endostatins | 3 | 2006 | 167 | 0.500 |
Why?
|
Animals | 84 | 2022 | 168965 | 0.500 |
Why?
|
Skin Pigmentation | 2 | 2014 | 280 | 0.500 |
Why?
|
Microfluidics | 1 | 2020 | 650 | 0.490 |
Why?
|
Carcinoma, Lewis Lung | 7 | 2008 | 106 | 0.480 |
Why?
|
Ischemia | 2 | 2021 | 1905 | 0.470 |
Why?
|
Endothelial Growth Factors | 8 | 2001 | 671 | 0.470 |
Why?
|
Polyesters | 3 | 2015 | 373 | 0.470 |
Why?
|
Capillary Permeability | 5 | 2013 | 772 | 0.470 |
Why?
|
Nerve Degeneration | 1 | 2018 | 748 | 0.460 |
Why?
|
Lymphokines | 8 | 2001 | 924 | 0.450 |
Why?
|
Disease Models, Animal | 17 | 2021 | 18330 | 0.450 |
Why?
|
Retinitis | 1 | 2013 | 36 | 0.430 |
Why?
|
Macular Degeneration | 4 | 2010 | 1015 | 0.430 |
Why?
|
Albinism, Oculocutaneous | 1 | 2013 | 19 | 0.420 |
Why?
|
Monophenol Monooxygenase | 1 | 2013 | 72 | 0.420 |
Why?
|
Peptides | 2 | 2017 | 4348 | 0.420 |
Why?
|
Glaucoma | 1 | 2022 | 1194 | 0.410 |
Why?
|
Neurotoxins | 1 | 2013 | 240 | 0.410 |
Why?
|
Eye Color | 1 | 2012 | 35 | 0.410 |
Why?
|
Chemokine CCL2 | 1 | 2014 | 605 | 0.390 |
Why?
|
Quantitative Trait Loci | 4 | 2012 | 2131 | 0.390 |
Why?
|
Neurites | 1 | 2013 | 389 | 0.380 |
Why?
|
Choroid | 4 | 2008 | 364 | 0.370 |
Why?
|
Extracellular Matrix | 1 | 2018 | 1733 | 0.360 |
Why?
|
Cell Movement | 9 | 2021 | 5203 | 0.350 |
Why?
|
Repressor Proteins | 1 | 2021 | 2979 | 0.340 |
Why?
|
Zebrafish | 3 | 2021 | 3036 | 0.340 |
Why?
|
Cells, Cultured | 13 | 2020 | 18989 | 0.330 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4401 | 0.310 |
Why?
|
Neoplasm Transplantation | 4 | 2007 | 2012 | 0.300 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 6 | 2012 | 547 | 0.300 |
Why?
|
Models, Biological | 4 | 2021 | 9464 | 0.300 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2012 | 627 | 0.300 |
Why?
|
Cell Hypoxia | 3 | 2008 | 661 | 0.290 |
Why?
|
Mice, SCID | 10 | 2007 | 2626 | 0.280 |
Why?
|
Laminin | 1 | 2008 | 404 | 0.280 |
Why?
|
Fertility | 2 | 2005 | 771 | 0.280 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4052 | 0.280 |
Why?
|
Membrane Proteins | 3 | 2021 | 7868 | 0.270 |
Why?
|
Polymorphism, Genetic | 2 | 2012 | 4247 | 0.240 |
Why?
|
Glycoproteins | 1 | 2012 | 2200 | 0.240 |
Why?
|
Endothelium, Vascular | 12 | 2013 | 4424 | 0.240 |
Why?
|
Lasers | 1 | 2009 | 951 | 0.230 |
Why?
|
Antigens, CD | 2 | 2012 | 4032 | 0.230 |
Why?
|
Vascular Endothelial Growth Factor C | 3 | 2018 | 125 | 0.230 |
Why?
|
Vascular Endothelial Growth Factors | 8 | 2001 | 748 | 0.230 |
Why?
|
Pigment Epithelium of Eye | 4 | 2014 | 209 | 0.220 |
Why?
|
Genome-Wide Association Study | 3 | 2021 | 12790 | 0.220 |
Why?
|
Hormones | 1 | 2007 | 865 | 0.210 |
Why?
|
Signal Transduction | 5 | 2021 | 23621 | 0.210 |
Why?
|
Dendritic Cells | 3 | 2009 | 2745 | 0.210 |
Why?
|
Thrombospondin 1 | 2 | 2022 | 257 | 0.210 |
Why?
|
Collagen | 2 | 2008 | 2636 | 0.200 |
Why?
|
Antigens, Bacterial | 1 | 2007 | 1148 | 0.200 |
Why?
|
Glutathione Peroxidase | 1 | 2023 | 259 | 0.200 |
Why?
|
Bacterial Toxins | 1 | 2007 | 922 | 0.190 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1188 | 0.190 |
Why?
|
Administration, Oral | 8 | 2015 | 4026 | 0.190 |
Why?
|
Plants | 1 | 2023 | 332 | 0.190 |
Why?
|
Bone Marrow Cells | 2 | 2007 | 2412 | 0.190 |
Why?
|
Sucralfate | 3 | 2014 | 12 | 0.190 |
Why?
|
Tubulin | 2 | 1996 | 694 | 0.190 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2014 | 3804 | 0.190 |
Why?
|
Cytokines | 4 | 2013 | 7446 | 0.180 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2255 | 0.180 |
Why?
|
Cytochalasins | 1 | 2000 | 19 | 0.180 |
Why?
|
Genes, Tumor Suppressor | 1 | 2005 | 1058 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2008 | 2270 | 0.180 |
Why?
|
Glutathione | 1 | 2023 | 589 | 0.180 |
Why?
|
Superoxide Dismutase | 1 | 2023 | 596 | 0.180 |
Why?
|
Apoptosis | 5 | 2020 | 9513 | 0.170 |
Why?
|
Stromal Cells | 1 | 2006 | 1335 | 0.170 |
Why?
|
Cell Division | 9 | 2003 | 4473 | 0.170 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11513 | 0.170 |
Why?
|
Mutation | 4 | 2013 | 30211 | 0.170 |
Why?
|
Ascorbic Acid | 1 | 2023 | 658 | 0.170 |
Why?
|
Endometrium | 3 | 2013 | 406 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2002 | 338 | 0.170 |
Why?
|
Transplantation, Heterologous | 2 | 2005 | 2391 | 0.160 |
Why?
|
Sulindac | 1 | 1999 | 29 | 0.160 |
Why?
|
Tumor Cells, Cultured | 7 | 2020 | 6106 | 0.160 |
Why?
|
Nerve Crush | 1 | 2018 | 77 | 0.160 |
Why?
|
Amiodarone | 1 | 2020 | 217 | 0.160 |
Why?
|
Genetic Variation | 3 | 2017 | 6611 | 0.160 |
Why?
|
Early Growth Response Protein 1 | 1 | 2018 | 133 | 0.160 |
Why?
|
Haplotypes | 2 | 2017 | 2722 | 0.150 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2018 | 149 | 0.150 |
Why?
|
Crosses, Genetic | 2 | 2013 | 751 | 0.150 |
Why?
|
Polyhydroxyethyl Methacrylate | 2 | 2014 | 30 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2018 | 118 | 0.150 |
Why?
|
Blotting, Western | 4 | 2012 | 5022 | 0.140 |
Why?
|
Rats | 4 | 2021 | 23713 | 0.140 |
Why?
|
Hematopoiesis | 1 | 2007 | 2056 | 0.140 |
Why?
|
Thrombopoietin | 1 | 1999 | 225 | 0.140 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 150 | 0.140 |
Why?
|
Mice, Transgenic | 7 | 2009 | 9551 | 0.140 |
Why?
|
Fluorescein Angiography | 4 | 2014 | 1086 | 0.140 |
Why?
|
Morphogenesis | 1 | 2021 | 746 | 0.140 |
Why?
|
Lymphangiogenesis | 1 | 2018 | 171 | 0.140 |
Why?
|
Hemangiosarcoma | 1 | 1999 | 214 | 0.140 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 301 | 0.140 |
Why?
|
Peptide Hydrolases | 2 | 2012 | 610 | 0.140 |
Why?
|
Cell Separation | 2 | 2020 | 1717 | 0.140 |
Why?
|
Genetic Heterogeneity | 1 | 2000 | 735 | 0.130 |
Why?
|
Amino Acids | 1 | 2022 | 1712 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 2020 | 988 | 0.130 |
Why?
|
Genitalia, Female | 1 | 1997 | 146 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2018 | 582 | 0.130 |
Why?
|
Parkinson Disease, Secondary | 2 | 1987 | 120 | 0.130 |
Why?
|
Immunohistochemistry | 7 | 2012 | 11063 | 0.130 |
Why?
|
Humans | 51 | 2023 | 767040 | 0.130 |
Why?
|
Cell Growth Processes | 2 | 2007 | 380 | 0.130 |
Why?
|
Antineoplastic Agents | 5 | 2008 | 13650 | 0.130 |
Why?
|
Receptors, Notch | 1 | 2020 | 751 | 0.130 |
Why?
|
Calcium-Binding Proteins | 1 | 2020 | 1081 | 0.130 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2018 | 633 | 0.120 |
Why?
|
Alleles | 2 | 2022 | 6893 | 0.120 |
Why?
|
Species Specificity | 4 | 2004 | 2412 | 0.120 |
Why?
|
Antioxidants | 1 | 2023 | 1671 | 0.120 |
Why?
|
Laser Coagulation | 2 | 2008 | 335 | 0.120 |
Why?
|
Micelles | 1 | 2015 | 190 | 0.120 |
Why?
|
Hemangioma | 1 | 1999 | 727 | 0.120 |
Why?
|
Neoplasms | 7 | 2011 | 22350 | 0.110 |
Why?
|
Pigmentation | 1 | 2014 | 143 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1405 | 0.110 |
Why?
|
Retinal Neovascularization | 2 | 2014 | 287 | 0.110 |
Why?
|
Multiple Myeloma | 2 | 2002 | 5186 | 0.110 |
Why?
|
Polymers | 3 | 2015 | 1624 | 0.110 |
Why?
|
Cell Proliferation | 6 | 2022 | 10455 | 0.110 |
Why?
|
Genetic Linkage | 2 | 2013 | 2342 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 1999 | 1228 | 0.110 |
Why?
|
Mice, Nude | 4 | 2020 | 3618 | 0.110 |
Why?
|
Chromosome Mapping | 3 | 2009 | 4616 | 0.110 |
Why?
|
Down-Regulation | 1 | 2020 | 2931 | 0.110 |
Why?
|
Spironolactone | 1 | 1996 | 415 | 0.100 |
Why?
|
Neuroglia | 1 | 2018 | 960 | 0.100 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.100 |
Why?
|
Protein Binding | 2 | 2017 | 9327 | 0.100 |
Why?
|
Retinal Ganglion Cells | 1 | 2018 | 810 | 0.100 |
Why?
|
Growth Inhibitors | 2 | 2005 | 375 | 0.100 |
Why?
|
Green Fluorescent Proteins | 4 | 2011 | 2063 | 0.100 |
Why?
|
Retinal Dysplasia | 1 | 2011 | 12 | 0.100 |
Why?
|
Perfusion | 1 | 2017 | 1409 | 0.100 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 956 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1121 | 0.100 |
Why?
|
Microtubules | 2 | 1996 | 1062 | 0.100 |
Why?
|
Oxidative Stress | 1 | 2023 | 3139 | 0.100 |
Why?
|
Mice, Inbred BALB C | 2 | 2014 | 6226 | 0.100 |
Why?
|
Platelet Factor 4 | 1 | 2012 | 131 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 1999 | 1172 | 0.100 |
Why?
|
Delayed-Action Preparations | 2 | 2014 | 965 | 0.100 |
Why?
|
Catechin | 1 | 2011 | 70 | 0.090 |
Why?
|
Flow Cytometry | 4 | 2011 | 5891 | 0.090 |
Why?
|
Retina | 3 | 2018 | 2659 | 0.090 |
Why?
|
Drug Carriers | 1 | 2015 | 702 | 0.090 |
Why?
|
Glutamates | 3 | 1997 | 384 | 0.090 |
Why?
|
Injections, Intraperitoneal | 3 | 2001 | 411 | 0.090 |
Why?
|
Lactic Acid | 1 | 2015 | 1139 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8108 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2902 | 0.080 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 637 | 0.080 |
Why?
|
Retinal Vein Occlusion | 1 | 1991 | 149 | 0.080 |
Why?
|
Microcirculation | 1 | 2014 | 1282 | 0.080 |
Why?
|
Tea | 1 | 2011 | 289 | 0.080 |
Why?
|
3T3 Cells | 2 | 2002 | 1081 | 0.080 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2012 | 616 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2012 | 706 | 0.080 |
Why?
|
Interleukin-8 | 1 | 2012 | 704 | 0.080 |
Why?
|
Uveitis | 1 | 2013 | 398 | 0.080 |
Why?
|
Genotype | 3 | 2013 | 13035 | 0.080 |
Why?
|
Phosphorylation | 2 | 2018 | 8310 | 0.080 |
Why?
|
Paclitaxel | 1 | 1997 | 1728 | 0.080 |
Why?
|
Models, Animal | 2 | 2014 | 2121 | 0.080 |
Why?
|
Cell Transplantation | 2 | 2008 | 475 | 0.080 |
Why?
|
Intestine, Small | 1 | 2015 | 1217 | 0.080 |
Why?
|
Transfection | 3 | 2001 | 5753 | 0.080 |
Why?
|
Cattle | 4 | 2003 | 3813 | 0.080 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 156 | 0.080 |
Why?
|
Female | 23 | 2021 | 396660 | 0.080 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1168 | 0.080 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2007 | 5716 | 0.080 |
Why?
|
Epidermis | 1 | 2011 | 539 | 0.080 |
Why?
|
Structure-Activity Relationship | 3 | 2001 | 3052 | 0.080 |
Why?
|
Retinal Vessels | 2 | 1994 | 863 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3934 | 0.070 |
Why?
|
Th1 Cells | 1 | 2013 | 1040 | 0.070 |
Why?
|
Integrins | 1 | 2012 | 840 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2020 | 10748 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8628 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4572 | 0.070 |
Why?
|
Imipramine | 1 | 1987 | 96 | 0.070 |
Why?
|
Skin | 2 | 2011 | 4499 | 0.070 |
Why?
|
Rabbits | 4 | 1999 | 4751 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3608 | 0.070 |
Why?
|
In Situ Nick-End Labeling | 1 | 2008 | 610 | 0.070 |
Why?
|
Th17 Cells | 1 | 2013 | 790 | 0.070 |
Why?
|
Propylamines | 1 | 1987 | 161 | 0.070 |
Why?
|
Biological Assay | 2 | 2007 | 626 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3792 | 0.070 |
Why?
|
Receptors, Serotonin | 1 | 1987 | 210 | 0.070 |
Why?
|
Chick Embryo | 3 | 2003 | 973 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 348 | 0.070 |
Why?
|
Whole-Body Irradiation | 1 | 2007 | 435 | 0.060 |
Why?
|
NF-kappa B | 1 | 2014 | 2493 | 0.060 |
Why?
|
Receptors, Peptide | 1 | 2007 | 280 | 0.060 |
Why?
|
Diabetic Retinopathy | 1 | 1995 | 1300 | 0.060 |
Why?
|
Chromosomes | 1 | 2009 | 578 | 0.060 |
Why?
|
Estrous Cycle | 1 | 2006 | 65 | 0.060 |
Why?
|
Immunomodulation | 1 | 2009 | 548 | 0.060 |
Why?
|
Angiopoietins | 1 | 2006 | 86 | 0.060 |
Why?
|
Gene Expression Regulation | 4 | 2012 | 11923 | 0.060 |
Why?
|
Phenotype | 3 | 2017 | 16718 | 0.060 |
Why?
|
Glioblastoma | 1 | 2020 | 3461 | 0.060 |
Why?
|
Thrombospondins | 1 | 2006 | 196 | 0.060 |
Why?
|
Male | 21 | 2018 | 364203 | 0.060 |
Why?
|
Stem Cells | 2 | 2011 | 3535 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1331 | 0.060 |
Why?
|
Ovulation | 1 | 2006 | 181 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1814 | 0.060 |
Why?
|
Genes | 1 | 2009 | 1824 | 0.060 |
Why?
|
Melanins | 1 | 1987 | 291 | 0.060 |
Why?
|
Antigens, Ly | 1 | 2006 | 297 | 0.060 |
Why?
|
RNA, Catalytic | 1 | 2004 | 52 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1889 | 0.060 |
Why?
|
Environmental Pollution | 1 | 1985 | 125 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2009 | 17097 | 0.060 |
Why?
|
Acetaminophen | 1 | 2008 | 549 | 0.060 |
Why?
|
Drug Combinations | 2 | 2008 | 2086 | 0.060 |
Why?
|
Vision Disorders | 1 | 1991 | 1090 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2008 | 1442 | 0.050 |
Why?
|
Fibroblast Growth Factors | 2 | 2007 | 873 | 0.050 |
Why?
|
Colchicine | 2 | 1996 | 256 | 0.050 |
Why?
|
Cadherins | 1 | 2008 | 903 | 0.050 |
Why?
|
Macrophage-Activating Factors | 1 | 2003 | 21 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2004 | 624 | 0.050 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2005 | 361 | 0.050 |
Why?
|
Vascular Diseases | 1 | 1991 | 1161 | 0.050 |
Why?
|
Luminescent Proteins | 2 | 2002 | 839 | 0.050 |
Why?
|
Regeneration | 1 | 2011 | 1523 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2006 | 750 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1130 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2013 | 5499 | 0.050 |
Why?
|
Bone Marrow Transplantation | 2 | 2011 | 2710 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1969 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2006 | 723 | 0.050 |
Why?
|
Cell Membrane | 2 | 2008 | 3642 | 0.050 |
Why?
|
Vitamin D-Binding Protein | 1 | 2003 | 130 | 0.050 |
Why?
|
Mice, Inbred NOD | 1 | 2006 | 1837 | 0.050 |
Why?
|
X Chromosome | 1 | 2005 | 819 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2013 | 3468 | 0.050 |
Why?
|
Follicular Phase | 1 | 2002 | 143 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2002 | 456 | 0.050 |
Why?
|
Corpus Luteum | 2 | 2002 | 81 | 0.050 |
Why?
|
Evans Blue | 1 | 2001 | 42 | 0.050 |
Why?
|
Visual Acuity | 1 | 1991 | 2714 | 0.050 |
Why?
|
Genes, Dominant | 1 | 2003 | 855 | 0.040 |
Why?
|
Bromodeoxyuridine | 1 | 2001 | 310 | 0.040 |
Why?
|
Mycotoxins | 1 | 2000 | 35 | 0.040 |
Why?
|
Ovarian Follicle | 1 | 2002 | 243 | 0.040 |
Why?
|
Mammals | 1 | 2006 | 1135 | 0.040 |
Why?
|
Aspergillus | 1 | 2000 | 94 | 0.040 |
Why?
|
Blood Vessels | 1 | 2006 | 1110 | 0.040 |
Why?
|
Adenoviridae | 2 | 2001 | 1092 | 0.040 |
Why?
|
Receptors, Growth Factor | 1 | 2001 | 324 | 0.040 |
Why?
|
Stimulation, Chemical | 1 | 1999 | 305 | 0.040 |
Why?
|
Aminopeptidases | 1 | 2000 | 114 | 0.040 |
Why?
|
Binding, Competitive | 2 | 1994 | 1141 | 0.040 |
Why?
|
Wound Healing | 1 | 2011 | 2800 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2001 | 678 | 0.040 |
Why?
|
Eye Neoplasms | 1 | 2001 | 305 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2004 | 935 | 0.040 |
Why?
|
Hemangioendothelioma | 1 | 1999 | 112 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 2000 | 386 | 0.040 |
Why?
|
Eye | 1 | 2022 | 711 | 0.040 |
Why?
|
Coloring Agents | 1 | 2001 | 565 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2815 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2001 | 11097 | 0.040 |
Why?
|
Pyridines | 2 | 1987 | 2890 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2006 | 17608 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2013 | 11657 | 0.040 |
Why?
|
Up-Regulation | 2 | 2011 | 4143 | 0.040 |
Why?
|
Transgenes | 1 | 2001 | 1014 | 0.040 |
Why?
|
Estrus | 1 | 1997 | 70 | 0.040 |
Why?
|
Gene Expression | 2 | 2008 | 7587 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 1997 | 116 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2002 | 862 | 0.030 |
Why?
|
Random Allocation | 2 | 2011 | 2394 | 0.030 |
Why?
|
Kinetics | 3 | 1997 | 6287 | 0.030 |
Why?
|
Decidua | 1 | 1997 | 82 | 0.030 |
Why?
|
Extraembryonic Membranes | 1 | 1996 | 37 | 0.030 |
Why?
|
Platelet Count | 1 | 1999 | 784 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2018 | 321 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2001 | 1621 | 0.030 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 1987 | 88 | 0.030 |
Why?
|
Fluoresceins | 2 | 1994 | 235 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 13411 | 0.030 |
Why?
|
Plasminogen Activators | 1 | 1996 | 199 | 0.030 |
Why?
|
Podophyllotoxin | 1 | 1996 | 20 | 0.030 |
Why?
|
Melanoma | 2 | 2012 | 5702 | 0.030 |
Why?
|
Plasmids | 1 | 2001 | 2268 | 0.030 |
Why?
|
Drug Implants | 1 | 1996 | 230 | 0.030 |
Why?
|
src-Family Kinases | 1 | 2018 | 539 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1996 | 324 | 0.030 |
Why?
|
Light Coagulation | 1 | 1995 | 72 | 0.030 |
Why?
|
Genetic Vectors | 2 | 2004 | 3402 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3599 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2022 | 14476 | 0.030 |
Why?
|
Stilbenes | 1 | 1996 | 155 | 0.030 |
Why?
|
Sulfonamides | 1 | 2005 | 1982 | 0.030 |
Why?
|
RNA, Messenger | 5 | 2013 | 12793 | 0.030 |
Why?
|
Dextrans | 2 | 1994 | 574 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2015 | 364 | 0.030 |
Why?
|
Cryotherapy | 1 | 1995 | 164 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2001 | 3093 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 2015 | 400 | 0.030 |
Why?
|
Pyrazoles | 1 | 2005 | 2028 | 0.030 |
Why?
|
RNA Interference | 1 | 2022 | 2829 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2001 | 2093 | 0.030 |
Why?
|
Chemotaxis | 1 | 1996 | 598 | 0.030 |
Why?
|
Syndrome | 1 | 1999 | 3271 | 0.030 |
Why?
|
Uterus | 1 | 1997 | 661 | 0.030 |
Why?
|
Leukocytes | 1 | 2001 | 2034 | 0.030 |
Why?
|
Interleukin-12 | 1 | 1995 | 577 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 1999 | 6507 | 0.020 |
Why?
|
Aorta | 1 | 2000 | 2045 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6966 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2002 | 3227 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2001 | 4522 | 0.020 |
Why?
|
Eye Enucleation | 1 | 2011 | 128 | 0.020 |
Why?
|
Aqueous Humor | 1 | 2011 | 152 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2168 | 0.020 |
Why?
|
Granulation Tissue | 1 | 2011 | 92 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1997 | 1676 | 0.020 |
Why?
|
Occlusive Dressings | 1 | 2011 | 52 | 0.020 |
Why?
|
beta-Galactosidase | 2 | 2003 | 573 | 0.020 |
Why?
|
Endocytosis | 1 | 2015 | 951 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 1996 | 1164 | 0.020 |
Why?
|
Gliosis | 1 | 2011 | 246 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1994 | 2551 | 0.020 |
Why?
|
Tensile Strength | 1 | 2011 | 332 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 1996 | 1074 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2144 | 0.020 |
Why?
|
Age Factors | 2 | 2001 | 18401 | 0.020 |
Why?
|
Cell Line | 2 | 2004 | 15567 | 0.020 |
Why?
|
Pregnancy | 2 | 2005 | 30238 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1997 | 1939 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 8940 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 1997 | 21178 | 0.020 |
Why?
|
Survival Rate | 2 | 2003 | 12823 | 0.020 |
Why?
|
Culture Media, Conditioned | 2 | 2003 | 521 | 0.020 |
Why?
|
Retinopathy of Prematurity | 1 | 1994 | 450 | 0.020 |
Why?
|
Eye Proteins | 1 | 2011 | 628 | 0.020 |
Why?
|
Adherens Junctions | 1 | 2008 | 90 | 0.020 |
Why?
|
Blood Platelets | 1 | 1998 | 2464 | 0.020 |
Why?
|
p-Chloroamphetamine | 1 | 1987 | 7 | 0.020 |
Why?
|
Pancreatic Neoplasms | 2 | 2003 | 5446 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2001 | 559 | 0.020 |
Why?
|
Homovanillic Acid | 1 | 1987 | 73 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7210 | 0.020 |
Why?
|
Retinal Detachment | 1 | 2011 | 429 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 2008 | 491 | 0.020 |
Why?
|
Binding Sites | 1 | 1996 | 6014 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 18063 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7611 | 0.020 |
Why?
|
Tritium | 1 | 1987 | 707 | 0.020 |
Why?
|
Monoamine Oxidase | 1 | 1987 | 179 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2008 | 13491 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 585 | 0.020 |
Why?
|
Autoradiography | 1 | 1987 | 725 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2011 | 1673 | 0.020 |
Why?
|
Putamen | 1 | 1987 | 288 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1987 | 2078 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1987 | 367 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2850 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1997 | 4349 | 0.020 |
Why?
|
Chloroquine | 1 | 1987 | 276 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 1987 | 388 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2008 | 408 | 0.020 |
Why?
|
Substantia Nigra | 1 | 1987 | 346 | 0.020 |
Why?
|
Toyocamycin | 1 | 2004 | 4 | 0.020 |
Why?
|
Macaca fascicularis | 1 | 1987 | 908 | 0.010 |
Why?
|
Base Pairing | 1 | 2004 | 139 | 0.010 |
Why?
|
Citalopram | 1 | 1987 | 402 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6215 | 0.010 |
Why?
|
Receptor, TIE-2 | 1 | 2005 | 183 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3427 | 0.010 |
Why?
|
Allantois | 1 | 2003 | 32 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1987 | 2275 | 0.010 |
Why?
|
Catalysis | 1 | 2004 | 766 | 0.010 |
Why?
|
Chorion | 1 | 2003 | 113 | 0.010 |
Why?
|
Neuraminidase | 1 | 2003 | 192 | 0.010 |
Why?
|
Serotonin | 1 | 1987 | 1045 | 0.010 |
Why?
|
Angiostatins | 1 | 2002 | 64 | 0.010 |
Why?
|
Plasminogen | 1 | 2002 | 144 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2004 | 561 | 0.010 |
Why?
|
Infusions, Parenteral | 1 | 2001 | 395 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2008 | 1894 | 0.010 |
Why?
|
Osmotic Pressure | 1 | 2001 | 136 | 0.010 |
Why?
|
Drug Stability | 1 | 2001 | 289 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12158 | 0.010 |
Why?
|
Tomography, Optical Coherence | 1 | 2014 | 2954 | 0.010 |
Why?
|
Paraffin Embedding | 1 | 2002 | 303 | 0.010 |
Why?
|
Infusion Pumps, Implantable | 1 | 2001 | 158 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 2001 | 439 | 0.010 |
Why?
|
Cricetinae | 1 | 2004 | 2415 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 1526 | 0.010 |
Why?
|
Brain | 1 | 1987 | 27163 | 0.010 |
Why?
|
Dopamine | 1 | 1987 | 1581 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2003 | 554 | 0.010 |
Why?
|
Fibrosarcoma | 1 | 2001 | 313 | 0.010 |
Why?
|
Organ Specificity | 1 | 2004 | 1966 | 0.010 |
Why?
|
Adenosine | 1 | 2004 | 812 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 2002 | 822 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2011 | 3698 | 0.010 |
Why?
|
Corpus Striatum | 1 | 1985 | 1217 | 0.010 |
Why?
|
Oxygen | 1 | 2011 | 4252 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2001 | 1623 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 6000 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14766 | 0.010 |
Why?
|
Cell Count | 1 | 2002 | 1825 | 0.010 |
Why?
|
Progesterone | 1 | 2002 | 752 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 661 | 0.010 |
Why?
|
Retinal Degeneration | 1 | 2001 | 413 | 0.010 |
Why?
|
Neurons | 2 | 1987 | 9517 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2003 | 1560 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14672 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1997 | 861 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1207 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1550 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2002 | 2345 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 1997 | 384 | 0.010 |
Why?
|
Cell Survival | 1 | 2005 | 5750 | 0.010 |
Why?
|
Capillaries | 1 | 1997 | 755 | 0.010 |
Why?
|
Prevalence | 1 | 1991 | 15851 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12414 | 0.010 |
Why?
|
Adult | 3 | 2012 | 223317 | 0.010 |
Why?
|
Fundus Oculi | 1 | 1994 | 560 | 0.010 |
Why?
|
Lectins | 1 | 1994 | 490 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1994 | 564 | 0.010 |
Why?
|
Prognosis | 1 | 1991 | 29963 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 1991 | 39317 | 0.010 |
Why?
|
Antibodies | 1 | 1997 | 2419 | 0.010 |
Why?
|
Aged | 2 | 2012 | 171319 | 0.000 |
Why?
|
Macrophages | 1 | 2003 | 5785 | 0.000 |
Why?
|
Middle Aged | 2 | 2012 | 223233 | 0.000 |
Why?
|
Interferon-gamma | 1 | 1995 | 3154 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1997 | 5796 | 0.000 |
Why?
|
Acute Disease | 1 | 1996 | 7236 | 0.000 |
Why?
|
Adolescent | 1 | 2011 | 89046 | 0.000 |
Why?
|
Anticoagulants | 1 | 1998 | 4854 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 65295 | 0.000 |
Why?
|
Chronic Disease | 1 | 1996 | 9362 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 1994 | 20169 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1994 | 26396 | 0.000 |
Why?
|